Lung Cancer

 

Epidemiology

leading cause of cancer mortality

incidence: 60/100,000 in males; 40/100,000 in females

female lung cancer has increased 400%.

male lung cancer rates are decreasing.

 

Signs and Symptoms

 

cough: change in pattern: increasing

hemoptysis

shortness of breath: though not normally an initial symptom

pneumonia - persistent or recurrent, especially in same area

abnormal chest X-ray

nonpulmonary thoracic symptoms

 

Peripheral nodules: no symptoms until it touches chest wall

central airway tumours:

airway obstruction, segmental lung collapse, infection, ventilation-perfusion mismatch, hemoptysis

metastatic disease: bone, brain, adrenals, liver

 

paraneoplastic syndromes

perhaps 50-75

not due to physical spread.

hypertrophic pulmonary osteoarthopathy (HPO) - pain at the ends of distal long bones.

syndrome of inappropriate ADH - low [sodium]

ACTH, other hormonal abnormalities

CNS

hematological abnormalities - anemia, thrombocytopenia

 

 

 

return to top

 

Differential Diagnosis

physical examination: feel for supraclavicular nodes

blood work: alkaline phosphatase

chest X ray

CT scan

timely referral

 

 

 

 

 

 

Diagnosis

bronchoscopy and chest x ray

CT scan

selective mediastinoscopy

needle biopsy usually for patients with inoperable tumours

 

mediastinal nodal involvement: poor prognosis

 

stage IIIa: mediastinal nodes; locally advanced tumour; small chance of cure

stage IV: metastatic

 

 

high suspicion: surgery

uncertin: serial CT scans or surgery

low suspicion: serial CT scans

PET scans in the future

 

 

return to top

 

 

Types of Lung Cancer

 

Non-small cell carcinoma

80%

squamous cell carcinoma

adenocarcinoma

bronchoalveolar

large cell anaplastic

 

Small cell carcinoma

 

 

Pathophysiology

 

 

 

 

return to top

 

 

Causes and Risk Factors

 

Smoking causes 85% of cases.

Remaining cancers are caused by

 

return to top

 

Treatments

 

Decisions

cell type, stage, patient

 

cure:

non small cell, stage 1: surgery: 65-80%

stage II surgery/chemo: 40-55%

small cell limited stage: xxxx 20%

 

lobectomy, pulmonectomy, chemotherapy, all have risk of mortality

 

palliation:

 

 

 

return to top

 

 

Course

 

cure:

stage I: 60-80%

stage II: 40-55%

stage III: 10-15%

stage IV: 1-2%

 

return to top

 

Patient Education

 

 

 

return to top

 

Community Resources

 

 

 

return to top

 

 

 

References